Herbas VPB

Print
EN | LT
LT - CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER`S CONGENITAL AMAUROSIS 10 (LCA10)
EN - CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER`S CONGENITAL AMAUROSIS 10 (LCA10)

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 15/113
A61K 31/7088
C12N 9/22
C12N 15/86
A61K 48/00
European patent
(11) Number of the document 3116997
(13) Kind of document T
(96) European patent application number 15714320.7
Date of filing the European patent application 2015-03-10
(97) Date of publication of the European application 2017-01-18
(45) Date of publication and mention of the grant of the patent 2019-05-15
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/019790
Date 2015-03-10
PCT application publication
(87) Number WO 2015/138510
Date 2015-09-17
Priority applications
(30) Number Date Country code
201461950733 P 2014-03-10 US
201462036576 P 2014-08-12 US
Inventors
(72)
MAEDER, Morgan, L., US
BUMCROT, David, A., US
SHEN, Shen, US
Grantee
(73) Editas Medicine, Inc., 11 Hurley Street, Cambridge, MA 02141, US
Title
(54) CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER`S CONGENITAL AMAUROSIS 10 (LCA10)
  CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER`S CONGENITAL AMAUROSIS 10 (LCA10)
Last update date 2021-04-30